Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PYC THERAPEUTICS LIMITED Capital/Financing Update 2015

Aug 10, 2015

65640_rns_2015-08-10_2abf3593-f4a5-4a7b-9034-57bc4d6be08b.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

==> picture [39 x 34] intentionally omitted <==

11[th] August 2015

Market Announcements Platform Australian Securities Exchange

Dear Sir

Entitlement Issue Result and Shortfall

Phylogica Limited advises that the Entitlement Offer and Shortfall Offer has concluded with acceptances for 87.2% of the issue.

Shares % of issue
Entitlement Acceptances 774,147,140 77.3
Shareholder applications for additional shares 99,559,831 9.9
Underwriter shortfall commitment 128,362,396 12.8
Total issue 1,002,069,367 100.0

Receipts from shareholders were $8,737,069.71

The underwriter shortfall commitment amounts to $1,283,623.96

Yours faithfully Phylogica Limited

==> picture [139 x 68] intentionally omitted <==

Graeme Boden

Company Secretary

PO Box 8207, Subiaco East, Western Australia 6008 Tel: +61 8 9384 3284 Fax: +61 8 9284 3801 www.phylogica.com ABN 48 098 391 961